This information was published on 2020-05-13T16:30:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2065599 (IR 1511612) |
| (220) |
19 Dec 2019
|
| (300) |
US, 21 Jun 2019, 88484229
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders. |
| (540) | ALEZURIS |
| (550) | Word |
| (730) |
Tricida, Inc.
|
Find out more about publications on the About page.